Trademark: 97786978
Word
TESORAI
Status
Pending
Status Code
688
Status Date
Tuesday, September 10, 2024
Serial Number
97786978
Mark Type
4
Filing Date
Wednesday, February 8, 2023
Published for Opposition
Tuesday, July 16, 2024

Trademark Owner History
Miao, Melissa - Owner At Publication

Classifications
9 Downloadable mobile application software, downloadable computer software, and recorded computer software featuring technology that allows users to analyze mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Downloadable mobile application software, downloadable computer software, and recorded computer software for research services to support pharmaceutical and biotech research and drug development; Downloadable mobile application software, downloadable computer software, and recorded computer software for data analytics, data preprocessing, data filtering and ranking, all of which in the fields of pharmaceutical and biotech research and drug development; Downloadable mobile application software, downloadable computer software, and recorded computer software featuring technology that allows users to to view, manipulate, and analyze data, information and reports in the fields of pharmaceutical and biotech research and drug development
5 Pharmaceutical and medical therapeutics for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders, namely, infectious disease, women's health disorders, mental health disorders; Pharmaceutical and medical preparations for the treatment of oncology, immunology, metabolic disorders, neurology, rare genetic disorders, psychiatric disorders, gastroenterology, renal disease, cardiovascular disease, dermatology, respiratory disease, bone disease, sexual dysfunction, ocular disease, hearing disorders and other related diseases and disorders, namely, infectious disease, women's health disorders, mental health disorders
42 Scientific and technological services as well as research and design services relating thereto, namely, research services to support pharmaceutical and biotech research and clinical development; Industrial analysis and research services, namely, mass spectrometry services and life sciences research services; Scientific research; Preclinical development of therapeutic products; Design and development of software; Laboratory testing; Chemical and biological laboratory services; Consultancy relating to laboratory testing; Data analytics services in the life sciences industry, namely, raw data preprocessing via artificial intelligence-enabled pipelines that preprocess mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Data filtering and ranking services in the life sciences industry, namely, the development of algorithms to optimize ranking of interactions and hits from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of computational models in the life sciences industry that predict interactions from mass spectrometry and sequencing data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Development of analytical approaches to generate novel biology and disease insights both from models and data in the fields of proteomics, genomics, epigenomics, transcriptomics, chemoproteomics, metabolomics, systems biology, flow cytometry, structural biology, and imaging data; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for research services to support pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software for data analytics, data preprocessing, data filtering and ranking, all of which in the fields of pharmaceutical and biotech research and drug development; Providing an online non-downloadable interactive web-based Software as a Service (SaaS) platform featuring software that allows users to view, manipulate, and analyze data, information and reports in the fields of pharmaceutical and biotech research and drug development

Trademark Events
Feb 11, 2023
New Application Entered
Feb 28, 2023
New Application Office Supplied Data Entered
Nov 6, 2023
Assigned To Examiner
Nov 14, 2023
Non-Final Action Written
Nov 14, 2023
Non-Final Action E-Mailed
Nov 14, 2023
Notification Of Non-Final Action E-Mailed
Nov 17, 2023
Teas Response To Office Action Received
Mar 19, 2024
Correspondence Received In Law Office
Mar 19, 2024
Teas/Email Correspondence Entered
Mar 19, 2024
Approved For Pub - Principal Register
Apr 2, 2024
Withdrawn From Pub - Og Review Query
Apr 24, 2024
Previous Allowance Count Withdrawn
Apr 29, 2024
Notification Of Non-Final Action E-Mailed
Apr 29, 2024
Non-Final Action Written
Apr 29, 2024
Non-Final Action E-Mailed
Jun 4, 2024
Correspondence Received In Law Office
Jun 5, 2024
Teas/Email Correspondence Entered
Jun 7, 2024
Approved For Pub - Principal Register
Jun 26, 2024
Notification Of Notice Of Publication E-Mailed
Jul 16, 2024
Published For Opposition
Jul 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2024
Published For Opposition
Jul 16, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 10, 2024
Noa E-Mailed - Sou Required From Applicant
Jun 4, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24